Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Resmed (GB:0KW4)
LSE:0KW4
Resmed (0KW4) Share Price & Analysis
1 Followers
0KW4 Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$131.91 - $237.56
Previous Close$173.86
Volume2.78K
Average Volume (3M)3.23K
Market Cap
$25.57B
Enterprise Value$26.75B
Total Cash (Recent Filing)$210.25M
Total Debt (Recent Filing)$1.39B
Price to Earnings (P/E)28.8
Beta1.00
Next Earnings
Apr 25, 2024EPS Estimate
$1.93Last Dividend Ex-Date
Feb 07, 2024Dividend Yield1.02%
Share Statistics
EPS (TTM)6.04
Shares Outstanding147,088,888
10 Day Avg. Volume21
30 Day Avg. Volume3,230
Standard Deviation0.07
R-Squared0.00427
Alpha0.02
Financial Highlights & Ratios
Price to Book (P/B)24.90
Price to Sales (P/S)7.02
Price to Cash Flow (P/CF)24.90
P/FCF Ratio26.10
Enterprise Value/Market CapN/A
Enterprise Value/Revenue6.68
Enterprise Value/Gross Profit11.36
Enterprise Value/Ebitda19.26
Forecast
1Y Price Target
$184.86Price Target Upside6.33% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering10
Resmed News
Bulls Say, Bears Say
Bulls Say
Market Share GainsRMD is positioned to maintain substantial US market share gains for a longer period than anticipated, supporting an EPS leverage thesis.
Revenue GrowthAnticipation of strong demand recovery in SaaS verticals could drive revenue growth.
Stock PerformanceAnalyst reiterates Buy rating with a price objective of 220.00 USD indicating confidence in the company's stock performance.
Bears Say
Financial ImpactThe ongoing recall process and high inventory levels present financial strains, with current inventory figures significantly exceeding pre-recall numbers.
Market PerceptionEmerging weight loss drugs could lead to a perception that CPAP therapy is less necessary, potentially decreasing demand for related products.
Regulatory ChallengesPhilips faces a permanent injunction on new CPAP sales, indicating a significant hurdle before re-entering the US market.
---
Options Prices
Currently, No data available
---
Ownership Overview
2.71% Insiders
21.71% Mutual Funds
22.99% Other Institutional Investors
52.59% Public Companies and
Individual Investors
0KW4 FAQ
What was Resmed’s price range in the past 12 months?
Resmed lowest share price was $131.91 and its highest was $237.56 in the past 12 months.
What is Resmed’s market cap?
Currently, no data Available
When is Resmed’s upcoming earnings report date?
Resmed’s upcoming earnings report date is Apr 25, 2024 which is in 6 days.
How were Resmed’s earnings last quarter?
Resmed released its earnings results on Jan 24, 2024. The company reported $1.88 earnings per share for the quarter, beating the consensus estimate of $1.776 by $0.104.
Is Resmed overvalued?
According to Wall Street analysts Resmed’s price is currently Undervalued.
Does Resmed pay dividends?
Resmed pays a Quarterly dividend of $0.48 which represents an annual dividend yield of 1.02%. See more information on Resmed dividends here
What is Resmed’s EPS estimate?
Resmed’s EPS estimate is $1.93.
How many shares outstanding does Resmed have?
Resmed has 147,088,880 shares outstanding.
What happened to Resmed’s price movement after its last earnings report?
Resmed reported an EPS of $1.88 in its last earnings report, beating expectations of $1.776. Following the earnings report the stock price went up 5.5%.
Which hedge fund is a major shareholder of Resmed?
Among the largest hedge funds holding Resmed’s share is Greenvale Capital LLP. It holds Resmed’s shares valued at 95M.
---
Resmed Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$184.86 (6.33% Upside)
$184.86 (6.33% Upside)
Blogger Sentiment
Bullish
GB:0KW4 Sentiment 100%
Sector Average 70%
Sector Average 70%
Insider Transactions
Sold Shares
Worth $5.0M over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-22.10%
12-Months-Change
Fundamentals
Return on Equity
21.66%
Trailing 12-Months
Asset Growth
3.43%
Trailing 12-Months
Company Description
Resmed
Founded in 1989, California-based ResMed, Inc. is a medical equipment company. The company is engaged in the development, manufacturing, distribution, and marketing of medical equipment and software solutions. The company operates through two segments: Sleep and Respiratory Care, and SaaS (Software as a Service).
---
0KW4 Company Deck
---
0KW4 Earnings Call
Q2 2024
0:00 / 0:00
---
0KW4 Revenue Breakdown
53.77% Devices
34.44% Masks and other
11.79% Software as a Service
---
0KW4 Stock 12 Months Forecast
Average Price Target
$184.86
▲(6.33% Upside)
Technical Analysis
Best Analysts Covering 0KW4
1 Year
1 Year Success Rate
9/16 ratings generated profit
1 Year Average Return
+0.06%
reiterated a buy rating 3 months ago
Copying David Low's trades and holding each position for 1 Year would result in 56.25% of your transactions generating a profit, with an average return of +0.06% per trade.
---